Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hull, J.
Right arrow Articles by Harris, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hull, J.
Right arrow Articles by Harris, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

OTHER

Abnormal mRNA splicing resulting from three different mutations in the CFTR gene

Jeremy Hull*, Sue Shackleton and Ann Harris

Paediatric Molecular Genetics, Institute of Molecular Medicine, John Radcliffe Hospital Oxford OX3 9DU, UK

* To whom correspondence should be addressed

Received February 2, 1993; Revised March 24, 1993; Accepted March 24, 1993

Three different putative splicing mutations in the CFTR gene have been studied by analysing mRNA extracted from nasal epithelial cells harvested from patients with cystic fibrosis. Six patients were analysed, all of whom had classical symptoms of cystic fibrosis (CF). Two patients carried the 621+1G -> T mutation, 3 patients carried the 1717–1G -> A mutation and 1 patient carried the 1898+1G -> A mutation. All patients carried the {Delta}F508 mutation on the other chromosome. Ten non-CF control subjects were also studied. The 621+1G -> T mutation resulted in activation of an alternative splice site within exon 4 in one patient and activation of this site or skipping of exon 4 in the other patient. The 1717–1G -> A mutation resulted in skipping of exon 11 in all 3 patients studied and the 1898+1G -> T mutation resulted in skipping of exon 12. These experiments demonstrate that these mutations do result in aberrant splicing of CFTR mRNA as predicted from the changes in genomic sequence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. Haque, E. Buratti, and F. E. Baralle
Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12
Nucleic Acids Res., November 12, 2009; (2009) gkp1040v1.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Adamia, A. A. Reichert, H. Kuppusamy, J. Kriangkum, A. Ghosh, J. J. Hodges, P. M. Pilarski, S. P. Treon, M. J. Mant, T. Reiman, et al.
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
Blood, December 15, 2008; 112(13): 5111 - 5121.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. Pagani, C. Stuani, M. Tzetis, E. Kanavakis, A. Efthymiadou, S. Doudounakis, T. Casals, and F. E. Baralle
New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12
Hum. Mol. Genet., May 15, 2003; 12(10): 1111 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Schibler, I. Bolt, S. Gallati, M.H. Schoni, and R. Kraemer
High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and {Delta}F508
Eur. Respir. J., June 1, 2001; 17(6): 1181 - 1186.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.